Catalog Number 1012841-40 |
Device Problems
Premature Activation (1484); Failure to Advance (2524)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 04/09/2023 |
Event Type
malfunction
|
Event Description
|
It was reported that the procedure was performed to treat a lesion in the biliary duct with 80% stenosis.The 8.0/40mm absolute pro self expanding stent system (sess) failed to cross the lesion after several attempts.Therefore, the sess was removed and the tip of the stent was noted flowered.Another absolute pro was used to complete the procedure.There were no adverse patient effects and no clinically significant delay in the procedure.No additional information was provided.
|
|
Manufacturer Narrative
|
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
|
|
Event Description
|
Subsequent to the initially filed report, the device was received, and the stent was not included with the rest of the device.The account stated that the stent was deployed outside anatomy and was discarded.No additional information was provided.
|
|
Manufacturer Narrative
|
The device was returned for analysis.The reported premature activation was unable to be confirmed due to the condition of the returned device (stent deployed).The reported failure to advance the device was unable to be replicated in a testing environment as it was based on operational circumstances.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.Additionally, a review of the complaint history did not indicate a lot specific quality issue.The investigation determined the reported difficulties appear to be related to circumstances of the procedure as it is likely that resistance was met with the 80% stenosed anatomy resulting in the reported failure to advance.Manipulation of the device resulted in the noted multiple distal sheath wrinkles and ultimately resulted in the reported premature activation (tip of the stent was noted flowered).As reported, the stent was deployed outside anatomy and was discarded.There is no indication of a product quality issue with respect to manufacture, design or labeling.
|
|
Search Alerts/Recalls
|